BIOMARIN PHARMACEUTICAL INC Derivative Asset, Noncurrent
BIOMARIN PHARMACEUTICAL INC (BMRN) had Derivative Asset, Noncurrent of $6.03 million as of 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DerivativeAssetsNoncurrent · last filed 2017-05-04
- 2017-03-31: Derivative Asset, Noncurrent $6.03M.
- 2016-12-31: Derivative Asset, Noncurrent $8.19M.
- 2016-09-30: Derivative Asset, Noncurrent $750.00K.
- 2016-06-30: Derivative Asset, Noncurrent $1.62M.
| Period end | Derivative Asset, Noncurrent |
|---|---|
| 2017-03-31 | $6.03M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $8.19M 10-Q · filed 2017-05-04 |
| 2016-09-30 | $750.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.62M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $734.00K 10-Q · filed 2016-05-02 |
| 2015-12-31 | $3.53M 10-K · filed 2017-02-27 |
| 2015-09-30 | $3.64M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $5.95M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $7.39M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $5.39M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |